Yuanyuan Ge, Meng Cao, Hui Cao, Bin Han, Jingchen Zhang, Zhengyu Yi, Yaowei Wu, Beifen Zhu, Keping Ruan, Yiyi Pu, Yi Zeng, Tongjing Tao, Zhenzhong Lyu, Hongmei Yuan, Guiliang Chen. Pharmaceutical digital transformation in China:
Digital Quality Assurance Takes the Driver’s Seat[J]. Journal of Zhejiang University Science ,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1007/s42242-023-00037-X
@article{title="Pharmaceutical digital transformation in China:
Digital Quality Assurance Takes the Driver’s Seat", author="Yuanyuan Ge, Meng Cao, Hui Cao, Bin Han, Jingchen Zhang, Zhengyu Yi, Yaowei Wu, Beifen Zhu, Keping Ruan, Yiyi Pu, Yi Zeng, Tongjing Tao, Zhenzhong Lyu, Hongmei Yuan, Guiliang Chen", journal="Journal of Zhejiang University Science ", year="in press", publisher="Zhejiang University Press & Springer", doi="https://doi.org/10.1007/s42242-023-00037-X" }
%0 Journal Article %T Pharmaceutical digital transformation in China:
Digital Quality Assurance Takes the Driver’s Seat %A Yuanyuan Ge %A Meng Cao %A Hui Cao %A Bin Han %A Jingchen Zhang %A Zhengyu Yi %A Yaowei Wu %A Beifen Zhu %A Keping Ruan %A Yiyi Pu %A Yi Zeng %A Tongjing Tao %A Zhenzhong Lyu %A Hongmei Yuan %A Guiliang Chen %J Journal of Zhejiang University SCIENCE %P %@ 2095-9184 %D in press %I Zhejiang University Press & Springer doi="https://doi.org/10.1007/s42242-023-00037-X"
TY - JOUR T1 - Pharmaceutical digital transformation in China:
Digital Quality Assurance Takes the Driver’s Seat A1 - Yuanyuan Ge A1 - Meng Cao A1 - Hui Cao A1 - Bin Han A1 - Jingchen Zhang A1 - Zhengyu Yi A1 - Yaowei Wu A1 - Beifen Zhu A1 - Keping Ruan A1 - Yiyi Pu A1 - Yi Zeng A1 - Tongjing Tao A1 - Zhenzhong Lyu A1 - Hongmei Yuan A1 - Guiliang Chen J0 - Journal of Zhejiang University Science SP - EP - %@ 2095-9184 Y1 - in press PB - Zhejiang University Press & Springer ER - doi="https://doi.org/10.1007/s42242-023-00037-X"
Abstract: The development of automation, the Internet of Things (IoT), artificial intelligence (AI), big data, and other digital technologies has made it imperative for pharmaceutical companies to undergo digital transformation to improve their research and development capabilities, increase the quality of their products, lower operating costs, and gain a competitive edge. One of the most crucial steps in the life-cycle risk management chain for drugs is digital quality assurance (DQA). Based on a literature review, questionnaire survey, and expert consensus, a panel of experts was convened in Shanghai to generate a set of conceptual, pharmaceutical manufacturing-specific DQA specifications. The goal of the consensus is to advance common practices that use digital tools to quickly collect, record, evaluate, and review particular forms of data to enhance the automation of quality assurance and make drug quality activities more efficient.
Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article
Reference
Open peer comments: Debate/Discuss/Question/Opinion
Open peer comments: Debate/Discuss/Question/Opinion
<1>